Table 1.

Number of samples and patient characteristics by site

CenterNo. of samples (no. of patients)EthnicityGenotype (no. of patients)Patient statusaAnalyses (reference)
Bangkok108 (25)AsianB (1); C (24)Receiving IFN-based treatmentOverall
Pisa128 (25)MediterraneanA (2); D (23)Receiving IFN-based or NA treatmentOverall, genotype, disease stage (4)
Hannover100 (20)Central EuropeanA (5); D (12); not available (3)Receiving IFN-based treatmentOverall, genotype, disease stage (10)
Melbourne91 (91)53% Asian, 34% Caucasian, 13% Middle EasternA (22), B (24), C (24), D (20), G (1)88% pretreatment, 4% receiving NAs, 8% status unknownOverall, genotype
Penzberg184 (184)Not availableA (3), B (1), C (1), D (1), E (6), F (1), not available (171)UntreatedOverall
  • a IFN, interferon; NA, nucleos(t)ide analog.